Literature DB >> 33211259

Mapping and functional characterization of murine kidney injury molecule-1 proteolytic cleavage site.

Saranga Sriranganathan1,2, Elena Tutunea-Fatan1, Alina Abbasi1, Lakshman Gunaratnam3,4,5.   

Abstract

Kidney injury molecule-1 (KIM-1), also known as T cell immunoglobulin and mucin domain 1 (TIM-1), is a transmembrane glycoprotein expressed on proximal tubule epithelia during acute kidney injury (AKI). Extracellular domain of KIM-1 undergoes spontaneous and activated ectodomain shedding into urine and blood via metalloproteases. Soluble KIM-1 (blood and urinary) is a reliable clinical biomarker of proximal tubular injury, but the biological significance of shedding remains unknown. The aim of this study was to identify the specific shedding enzyme and the proteolytic cleavage site of murine KIM-1, followed by the characterization of its functional relevance. In this regard, isoleucine (I) I202 was identified as the potential cleavage site. Mutation of isoleucine I202 to glutamine (I202Q) or alanine (I202A) significantly reduced both constitutive and induced KIM-1 shedding and ultimately efferocytosis. It was also uncovered that ADAM10 is the major sheddase that mediates the proteolytic cleavage of murine KIM-1. In addition, ADAM10-induced KIM-1 shedding was required for efficient phagocytic clearance of apoptotic cells. Importantly, the findings that the addition of exogenous shed KIM-1 rescued the phagocytic impairment suggest that shed KIM-1 is capable of modulating efferocytosis of apoptotic bodies and could represent a potential functional role of the soluble ectodomain KIM-1 during AKI.

Entities:  

Keywords:  Ectodomain shedding; Efferocytosis; Kidney injury molecule-1 (KIM-1); Proteolytic cleavage; TIM-1

Mesh:

Substances:

Year:  2020        PMID: 33211259     DOI: 10.1007/s11010-020-03975-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  48 in total

1.  Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury.

Authors:  T Ichimura; J V Bonventre; V Bailly; H Wei; C A Hession; R L Cate; M Sanicola
Journal:  J Biol Chem       Date:  1998-02-13       Impact factor: 5.157

2.  KIM-1-mediated phagocytosis reduces acute injury to the kidney.

Authors:  Li Yang; Craig R Brooks; Sheng Xiao; Venkata Sabbisetti; Melissa Y Yeung; Li-Li Hsiao; Takaharu Ichimura; Vijay Kuchroo; Joseph V Bonventre
Journal:  J Clin Invest       Date:  2015-03-09       Impact factor: 14.808

3.  Kidney injury molecule-1 expression in murine polycystic kidney disease.

Authors:  E Wolfgang Kuehn; Kwon Moo Park; Stefan Somlo; Joseph V Bonventre
Journal:  Am J Physiol Renal Physiol       Date:  2002-07-24

4.  G protein α12 (Gα12) is a negative regulator of kidney injury molecule-1-mediated efferocytosis.

Authors:  Ola Z Ismail; Xizhong Zhang; Joseph V Bonventre; Lakshman Gunaratnam
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-23

5.  Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma.

Authors:  Won K Han; Anwar Alinani; Chin-Lee Wu; Dror Michaelson; Massimo Loda; Francis J McGovern; Ravi Thadhani; Joseph V Bonventre
Journal:  J Am Soc Nephrol       Date:  2005-03-02       Impact factor: 10.121

6.  Tubular kidney injury molecule-1 (KIM-1) in human renal disease.

Authors:  M M van Timmeren; M C van den Heuvel; V Bailly; S J L Bakker; H van Goor; C A Stegeman
Journal:  J Pathol       Date:  2007-06       Impact factor: 7.996

7.  Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells.

Authors:  Takaharu Ichimura; Edwin J P V Asseldonk; Benjamin D Humphreys; Lakshman Gunaratnam; Jeremy S Duffield; Joseph V Bonventre
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

8.  Tubular kidney injury molecule-1 in protein-overload nephropathy.

Authors:  Mirjan M van Timmeren; Stephan J L Bakker; Vishal S Vaidya; Veronique Bailly; Theo A Schuurs; Jeffrey Damman; Coen A Stegeman; Joseph V Bonventre; Harry van Goor
Journal:  Am J Physiol Renal Physiol       Date:  2006-02-07

9.  Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes.

Authors:  Venkata S Sabbisetti; Sushrut S Waikar; Daniel J Antoine; Adam Smiles; Chang Wang; Abinaya Ravisankar; Kazumi Ito; Sahil Sharma; Swetha Ramadesikan; Michelle Lee; Rebeccah Briskin; Philip L De Jager; Thanh Thu Ngo; Mark Radlinski; James W Dear; Kevin B Park; Rebecca Betensky; Andrzej S Krolewski; Joseph V Bonventre
Journal:  J Am Soc Nephrol       Date:  2014-06-05       Impact factor: 10.121

10.  Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes.

Authors:  Natalia Nowak; Jan Skupien; Monika A Niewczas; Masayuki Yamanouchi; Melissa Major; Stephanie Croall; Adam Smiles; James H Warram; Joseph V Bonventre; Andrzej S Krolewski
Journal:  Kidney Int       Date:  2016-02       Impact factor: 10.612

View more
  1 in total

1.  KIM-1-mediated anti-inflammatory activity is preserved by MUC1 induction in the proximal tubule during ischemia-reperfusion injury.

Authors:  Mohammad M Al-Bataineh; Carol L Kinlough; Zaichuan Mi; Edwin K Jackson; Stephanie M Mutchler; David R Emlet; John A Kellum; Rebecca P Hughey
Journal:  Am J Physiol Renal Physiol       Date:  2021-06-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.